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Access to and Control over Plant Genetic Resources
for Food and Agriculture in South and Southern
Africa: How Many Wrongs Before a Right?
Debbie Collier*
“[I]f agriculture is in trouble, Africa is in trouble.”1
INTRODUCTION
Agriculture is pivotal in the lives of many Africans. In
southern Africa, approximately eighty percent of the population
is engaged in subsistence farming.2 Yet the agricultural output
in many African countries is inadequate to meet local needs.3
Food security in the region is negatively affected by a number
of past and present, and internal and external, factors that
include weather conditions, the colonial footprint, internal
conflict, international trade obligations, market reform, and the
impact of HIV/AIDS on community structure and livelihood.
Many countries in the region are ultimately forced to rely upon
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1. Donald L. Sparks, Economic Trends in Africa South of the Sahara, in
AFRICA SOUTH OF THE SAHARA 2003 11, 18 (Katharine Murison ed., 32d ed.
2003) (quoting the World Bank) (internal quotations omitted).
2. The majority of the labor force in developing Africa is employed in
agriculture, and typically agriculture can account for between thirty percent
and eighty percent of GDP. See id. at 18-19.
3. Although agricultural output unquestionably needs to be improved in
southern Africa, the sad reality is that often domestic agricultural output is
adequate to meet local needs. The output, however, is bound up in commercial
farming where much of the product is exported and, as many families lack the
economic power to purchase food, particularly in rural areas, they remain
hungry. Consider for example the plight of thousands of seasonal fruit pickers
who live in poverty in the prosperous Western Cape, South Africa. See
Andries du Toit, Hungry in the Valley of Plenty, MAIL & GUARDIAN, April 15 to
21, 2005, at 28; see also Michael R. Taylor & Jerry Cayford, American Patent
Policy, Biotechnology, and African Agriculture: The Case for Policy Change, 17
HARV. J.L. & TECH. 321, 328-29 (2004).
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food aid from international sources to feed their citizens.4
Part of the solution to food insecurity proffered in recent
years is the use of modern biotechnology5 in agriculture.6 This
solution has received a mixed response in southern Africa,7 and
in some countries the stance against genetically modified food
is so strong that even pervasive droughts and endemic hunger
were (almost) not enough to entice acceptance of genetically
modified food aid from the United States in 2002.8 On the
4. Heads of state and governments throughout the world have pledged
their commitment to achieve food security and to eradicate hunger “with an
immediate view to reducing the number of undernourished people to half their
present level no later than 2015.” Rome Declaration on World Food Security,
in ROME DECLARATION ON WORLD FOOD SECURITY AND WORLD FOOD SUMMIT
PLAN OF ACTION 1, 1 (1996); see also United Nations Millennium Declaration,
G.A. Res. 55/2, ¶ 19, U.N. Doc. A/RES/55/2 (Sept. 18, 2000).
5. Article 3 of the Cartagena Protocol defines modern biotechnology as:
[T]he application of: (a) In vitro nucleic acid techniques, including
recombinant deoxyribonucleic acid (DNA) and direct injection of
nucleic acid into cells or organelles, or (b) Fusion of cells beyond the
taxonomic family, that overcome natural physiological reproductive or
recombination barriers and that are not techniques used in
traditional breeding and selection.
SECRETARIAT OF THE CONVENTION ON BIOLOGICAL DIVERSITY, CARTAGENA
PROTOCOL ON BIOSAFETY TO THE CONVENTION ON BIOLOGICAL DIVERSITY 4
(2000) [hereinafter CARTAGENA PROTOCOL].
6. The use of biotechnology in agriculture and manufacturing is
commonplace and established: biotechnology has been used for centuries to
produce plant hybrids, foodstuffs and other products (such as fermentation in
the making of beer and the processes used in making cheese and yogurt).
Modern biotechnology, on the other hand, refers to new and controversial
techniques which involve the transfer of genes between species (genetic
engineering/genetic modification) in a manner and at a speed not previously
possible. See IQBAL PARKER ET AL., A NATIONAL BIOTECHNOLOGY STRATEGY
FOR SOUTH AFRICA 1-3 (2001). For example, the International Rice Research
Institute (IRRI) is involved in research and development into droughtresistant varieties of rice, and the Swaminathan Foundation in India is
developing salt-tolerant rice varieties. The University of Cape Town is
conducting research into the development of maize which is resistant to the
African endemic maize streak virus and which is tolerant to drought.
Nevertheless, there is a counterargument that modern biotechnology in
agriculture is not necessarily a useful tool in the fight against hunger and
poverty, and that, inter alia, it can result in monocultures and soil erosion.
See Cédric Cabanne, WIPO-UPOV Symposium on Intellectual Property Rights
in
Plant
Biotechnology
(Oct.
24,
2003),
http://www.upov.int/en/documents/Symposium2003/.
7. See Briefing, Service Centre for Development Cooperation, The TRIPS
Agreement: Patenting of Genetic Heritage and Food Security (Aug. 2003)
(stating that it is unclear “whether the cultivation of genetically modified
varieties is suited for the conditions of developing countries”).
8. Although Zambia stood by its rejection of the genetically modified
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other hand, South Africa, although not plagued by food
insecurity, but driven by industrial forces, has largely
Either way,
embraced genetically modified food crops.9
countries in Africa are moving forward in regulating modern
biotechnology.10
Resistance to the full-scale deployment of modern
biotechnology in agriculture is twofold. The predominant
objection is based upon environmental, human, and animal
health and safety concerns.11 These concerns are widely
documented12 and have resulted in the drafting of numerous
policy documents and legal instruments at national, regional,
and international levels. The second issue is that of control
and ownership of plant genetic resources and private
intellectual property rights in the products and processes of
crops, Lesotho, Malawi, and Mozambique eventually relented and accepted
some 60,000 tons of U.S. genetically modified food aid. See Taiwo A. Oriola,
Consumer Dilemmas: The Right to Know, Safety, Ethics and Policy of
Genetically Modified Food, SING. J. LEGAL STUD. 514, 514-15 & n.1 (2002).
Zimbabwe, an exporter of unmodified crops, agreed to accept U.S. genetically
modified maize on the condition that it would be allowed to mill the maize (at
its own cost) such that farmers would subsequently be incapable of replanting
it, and thus avoid the contamination of local crops. See id. at 515 n.1.
9. By 2000, some 350,000 hectares had already been planted with
genetically modified crops. See ELFRIEDA PSCHORN-STRAUSS & RACHEL
WYNBERG, THE SEEDS OF NEO-COLONIALISM: GENETIC ENGINEERING IN FOOD
AND FARMING 1 (Mark Butler & David Hallowes eds., 2002). More recently
the South African government appears to be exercising some caution: In early
2005, it was reported that the government rejected an application from Dow
Agrosciences to run field trials of GM maize in South Africa. See Bid to Test
GM Maize in SA Gets Thumbs Down, CAPE TIMES, Jan. 31, 2005. More
recently, the South African government has placed a moratorium on
genetically modified maize imports into South Africa while the Department of
Trade and Industry studies the implications of such imports. See Praise for
Oct.
28,
2005,
GM
Maize
Ruling,
NEWS24.COM,
http://www.news24.com/News24/South_Africa/News/0,,2-71442_1825155,00.html.
10. The African Centre for Biosafety has documented many of the
attempts to regulate biotechnology. See African Biosafety Laws & Comments,
http://www.biosafetyafrica.net/biosafety_laws_and_comments.htm (last visited
Feb. 16, 2006).
11. See Oriola, supra note 8, at 545-55 (outlining environmental and
public health concerns about potential adverse effects on biological diversity,
genetic resources, and human health).
12. See, e.g., African Centre for Biosafety, http://www.biosafetyafrica.net/
(last
visited
Feb.
16,
2006);
Biowatch
South
Africa,
http://www.biowatch.org.za/ (last visited Feb. 16, 2006). See generally Jeffrey
M. Smith, SEEDS OF DECEPTION: EXPOSING INDUSTRY AND GOVERNMENT LIES
ABOUT THE SAFETY OF THE GENETICALLY ENGINEERED FOODS YOU’RE EATING
(2003).

COLLIER FINAL

532

6/7/2006 6:29:21 PM

MINN. J.L. SCI. & TECH.

[Vol. 7:2

modern agricultural biotechnology.13
It is the latter, the control and ownership of plant genetic
resources and the ownership of intellectual property rights in
respect to plant genetic resources, which informs the thesis of
this article.
It is common knowledge that the global
intellectual property rights prescribed by the Agreement on
Trade-Related Aspects of Intellectual Property Rights (TRIPS
Agreement)14 conflict with the principles of the Convention on
Biological Diversity (CBD),15 in particular as they relate to
indigenous knowledge, and the control, access, and benefitsharing in plant genetic resources.16 Many African countries
have signed both TRIPS and the CBD and are now attempting
to reconcile the provisions in domestic law. In doing so, the
principles of the CBD and its associated instruments should
not, and indeed need not, be compromised.
The article will, in Part I, give a very broad, historical
overview of agriculture on the African continent. Part II will
inform the reader of international and regional environmental
law and intellectual property law instruments which aim to
regulate the control and ownership of plant genetic resources
and related biotechnological processes. Part III will then
consider domestic law (and the influence, in domestic law, of
the international instruments discussed in Part II) in southern
Africa, and particularly in South Africa. To conclude, Part IV
will review a case study of genetically modified cotton in South
Africa which illustrates the current regulatory framework.

13. See Andrew T. Mushita & Carol B. Thompson, Patenting Biodiversity?
Rejecting WTO/TRIPS in Southern Africa, 2 GLOBAL ENVTL. POL. 65 (2002).
14. Agreement on Trade-Related Aspects of Intellectual Property Rights,
Apr. 15, 1994, Marrakesh Agreement Establishing the World Trade
Organization, Annex IC, 1869 U.N.T.S. 299, 33 I.L.M. 1197 (1994) [hereinafter
TRIPS Agreement].
15. Convention on Biological Diversity, June 5, 1992, 31 I.L.M. 818
[hereinafter Convention on Biological Diversity].
16. See CATHERINE MONAGLE, CTR. FOR INT’L ENVTL. LAW & WORLD WIDE
FUND FOR NATURE, BIODIVERSITY & INTELLECTUAL PROPERTY RIGHTS:
REVIEWING INTELLECTUAL PROPERTY RIGHTS IN LIGHT OF THE OBJECTIVES OF
THE CONVENTION ON BIOLOGICAL DIVERSITY (2001); Sunita K. Sreedharan,
Reconciling TRIPs with the Convention on Biological Diversity – Indian
Perspective, BUSINESS BRIEFING: PHARMAGENERICS 2004, at 39-41 (2004).
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I. A BIRTHRIGHT OF ABUNDANCE AND A CULTURE OF
SHARING
Africa has an abundance of diversity: diversity of biological
resources, as well as diversity of culture. It is estimated that
Africa, home to more than 2000 different ethnic groups,17 holds
at least a quarter of the world’s biological diversity.18 Over
centuries, African communities developed sophisticated
agricultural practices, practices differing from those of other
world regions. As Devlin Kuyek explains:
In sub-Saharan Africa, farming began in Ethiopia between the 4th
and 6th millennia BC. Not long after, migrating pastoral peoples took
their agricultural practices to the rich, open lands of what is now
Kenya and Tanzania. In West Africa, the cultivation of millet began
in Mauritania at around 1000 BC, while rice cultivation began in the
Niger River Valley about a century later. At the same time,
communities in the West African forests started cultivating yam and
oil palm. Relative to other regions of the world, African farmers were
slow to take up sedentary agriculture practices. There were good
reasons for this. For one, they didn’t need to. African communities
generally had access to an abundance of land and could gather the
plants they needed for food and medicine by foraging. And, secondly,
for large parts of Africa, environmental conditions made continuous,
intensive agricultural production very difficult.19

Access by local communities to the rich diversity of
biological resources in Africa served as a shield against the
recurring human and environmental calamities to which Africa
is prone. The relationship between African communities and
Africa’s biological diversity was a mutually beneficial one: the
innovative agricultural practices helped to conserve and
sustain biodiversity.20 Indigenous communities classify,21 use,
17. See MARIAM MAYET, SECURING SUSTAINABLE LIVELIHOODS:
IMPERATIVES UNDERPINNING THE DEVELOPMENT OF AN APPROPRIATE REGIME
TO PROTECT COMMUNITY RIGHTS TO BIODIVERSITY 2 (2000).
18. DEVLIN KUYEK, GENETIC RESOURCES ACTION INT’L, INTELLECTUAL
PROPERTY RIGHTS IN AFRICAN AGRICULTURE: IMPLICATIONS FOR SMALL
FARMERS 11 (2002). South Africa alone is home to about ten percent of the
world’s plant biodiversity, and is home to one of the six floral kingdoms of the
world (the Cape Kingdom). See Michael Kidd & Mariam Mayet, Access to
Genetic Resources in South Africa, in AFRICAN PERSPECTIVES ON GENETIC
RESOURCES: A HANDBOOK ON LAWS, POLICIES, AND INSTITUTIONS GOVERNING
ACCESS AND BENEFIT-SHARING 231 (Kent Nnadozie et al. eds, 2003); Petro
Terblanche, Case Study: San/CSIR Hoodia Benefit-Sharing Model, in FOOD
SECURITY AND BIODIVERSITY: SHARING THE BENEFIT OF PLANT GENETIC
RESOURCES
61
(2003),
available
at
http://www.syngentafoundation.com/2004_review/World_Food_Day04.pdf.
19. KUYEK, supra note 18, at 2.
20. See MAYET, supra note 17. Systems for conservation include “home
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store, nurture, and cultivate a multitude of plant species.22 The
knowledge acquired by African communities over the centuries
is held collectively,23 but in recent years we have seen the
increasing value of indigenous knowledge in the global trading
market.24 The idea that knowledge is capable of private
ownership is alien to and “culturally inappropriate”25 for
indigenous communities in Africa which are characterized by
their communal approach to the use and management of plant
genetic resources.26
Oral traditions and agricultural practices of African
communities were directly, and indirectly, in the line of fire of
the colonial powers after the “scramble for Africa” in the
nineteenth century, which consolidated European interest and
influence in Africa that had existed since the mid-fifteenth
century European maritime explorations.27 Customary laws
and traditions gave way to colonial law,28 and artificial
gardens, seed banks, and sacred groves.” Id.
21. See Mushita & Thompson, supra note 13, at 74.
22. As explained by Kuyek:
The Suazi of Swaziland, for instance, nurture and use about 200 plant
species, and the Tembe Thonga of southern Africa regularly use 106
species for their daily needs. The Kpelle women in Liberia maintain
over 100 varieties of rice [and] . . . [i]n southern Africa, women are
reported to store seed of 10 ecotypes of sorghum and pearl millet at a
given period in their homestead granaries.
See KUYEK supra note 18, at 2.
23. Knowledge is generally acquired through membership of a community,
and measures are in place for the reciprocal exchange of information among
communities.
See Traditional African Concepts of Access, in AFRICAN
PERSPECTIVES ON GENETIC RESOURCES, supra note 18, at 25, 27.
24. The financial rewards, of course, accrue to the corporation exploiting
the resource. It is estimated that “[a]bout 75 percent of active ingredients in
pharmaceuticals come from plants in Southern countries.” Mushita &
Thompson, supra note 13, at 73. Mushita and Thompson provide the following
examples from Africa: the rosy periwinkle of Madagascar (exploited by Eli
Lilly to develop drugs for testicular cancer and childhood leukemia), an
Ethiopian crossbred barley (which previously saved the California crops from
yellow dwarf virus), and a West African berry (which contains a plant protein
2000 times sweeter than sugar). See id.
25. MONAGLE, supra note 16, at 15.
26. See Traditional African Concepts of Access, supra note 23.
27. See Richard Brown, European Colonial Rule in Africa, in AFRICA
SOUTH OF THE SAHARA, supra note 1, at 26, 26.
28. Legal systems in Africa are predominantly rooted in British common
law, French civil law, or Roman-Dutch civil law, and at the time of
colonization, colonial authorities were dismissive of indigenous legal systems.
See generally id. at 26-28.
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geographical boundaries created disharmony for local
communities. One such example is the Fulani in West Africa:
[T]he Fulani in West Africa . . . traditionally keep their livestock in
more arid areas during the wet season, where forage quality is
relatively high. In the dry season, when water becomes scarce in the
north, they move their animals further south to more humid areas,
where the livestock can graze the crop residues in harvested fields
and the still-green grass in low-lying areas along streams and rivers.
These herds are important sources of manure for arable farming and
thus help to maintain a cycle of cooperation and interdependence
between the pastoral and farming communities. However, this
particular system of resource use, amongst so many others, was
disturbed by the drawing of national boundaries by colonial powers
during the 19th and early 20th centuries.29

In many instances, sweeping changes to land use patterns
were implemented by the colonial authorities. Communities
were prohibited from cultivating certain crops without
authorization or outside of designated territories and were cut
off from their hunting and pastoral grounds, ultimately leading
to a “reduction in the use and subsequent loss of local varieties,
and the disruption of traditional farming systems that had
evolved and adapted to the local environments over the
centuries.”30
African communities were dealt a further blow by the soThe Green
called “Green Revolution”31 in the 1970s.
Revolution was the global “industrialization” of agriculture:
[The industrialization] started from the supply of biochemical
technologies not market demand, contributed little to agricultural
output and increased government debt. . . . [It] showed little respect
for the knowledge of African farmers and their proven capacities to
expand and adapt production to meet changing market conditions or
for the varied ecologies of African countries.32
29. See Traditional African Concepts of Access, supra note 23, at 29.
30. Id.
31. Advocates of genetically modified crops, in fact, liken the potential of
genetic modification to the Green Revolution. See STEPHEN GREENBERG,
AFRICAN CENTRE FOR BIOSAFETY, GLOBAL AGRICULTURE AND GENETICALLY
MODIFIED COTTON IN AFRICA 8-11 (2004).
32. Gavin Williams, Reforming Africa: Continuities and Changes, in
AFRICA SOUTH OF THE SAHARA 2003, supra note 1, at 3, 5. The Green
Revolution, in a different context, had transformed the production of grain in
Asia, although resulting in what is effectively a monoculture:
In India, over 75 percent of total rice production uses less than 10
percent of the 30,000 varieties of rice available. In Bangladesh, with
22 percent of the rice areas planted to modern varieties, 62 percent of
those are from one maternal parent. The current world food supply is
highly vulnerable.
Mushita & Thompson, supra note 13, at 75.
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The technology transferred to the developing South during
the Green Revolution consisted of high yielding seed varieties,
irrigation systems, and chemical (fertilizer and insecticide)
inputs from the developed North. Although higher yields may
well have been reached in some instances, the negative effect of
the pesticide use is still being felt in Africa today,33 as is the
social and economic impact of the Green Revolution, an illsuited and expensive exercise for small-scale farmers which
often resulted in the displacement of farm-laborers and the
marginalization of ill-resourced farmers.
The formal freedom from colonial rule has not been
successful in transforming the lives of many African people.
The United Nations classifies forty-nine countries as least
developed, thirty-four of which are found in Africa south of the
Sahara.34 External and internal factors have held Africa’s
potential at bay; disparities in income and inequality remain as
access to power and the means to material wealth often entice
those in power to move away from their stated agenda.35
II. PLANT GENETIC RESOURCES IN THE GLOBAL AND
REGIONAL CONTEXT
In the past, plant genetic resources for food and agriculture
were generally considered to be the “common heritage” of
humankind. Likewise, the technologies used to improve seeds
and plants were generally in the public domain.36 Farmers and
public research institutions that developed improved seeds
would share the fruits of their labor, and seeds would be saved
for exchange, sale, and cultivation.37 This is no longer so as
biotechnology companies clamber for intellectual property
protection for their products and processes. That private
33. See GREENBERG, supra note 31, at 10.
34. See Sparks, supra note 1, at 12.
35. See Williams, supra note 32, at 4-5.
36. A thread running through the diverse range of indigenous
communities in Africa is that which relates to ownership of property: the
concept of individual ownership of property is alien. Hence, land and genetic
(and biological) resources are communal in nature. See Traditional African
Concepts of Access, supra note 23, at 27-28.
37. It is estimated that ninety percent of food production in sub-Saharan
Africa is based on seeds saved for cultivation. See Service Centre for
Development Cooperation, supra note 7; see also Mushita & Thompson, supra
note 13, at 72.
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companies are winning in their fight to assert ownership over
plant genetic resources is evident from the decision of the
Canadian Supreme Court in Monsanto Canada, Inc. v.
Schmeiser.38
The recent availability of plant and biotechnology patents39
in many countries has been accompanied by a rise in the
commercial value of plants and seeds40 and a shift in the
balance of biotechnological research and development from the
public sector to private biotechnology entities.41 Private seed
38. [2004] S.C.R. 902 (Can.). In the Schmeiser case, Schmeiser had not
purchased Roundup Ready canola nor had he obtained a license to plant
Roundup Ready canola. See id. at 902. Tests, however, revealed that of
Schmeiser’s 1998 canola crop, some ninety-five to ninety-eight percent was
Roundup Ready canola. See id. at 907. Schmeiser suspected that the seed had
either blown onto his property from neighboring fields or fallen from passing
trucks. See Bernard Shaw, Monsanto Wins Patent Case on Plant Genes, N.Y.
TIMES, May 22, 2004, at C1. Nevertheless, Monsanto brought an action
against Schmeiser for patent infringement. See Schmeiser, [2004] S.C.R. at
907. The majority (5-to-4) in the Canadian Supreme Court upheld the patent
on the basis that protection extended to the genes and modified cells that
made up the plant (rather than the plant itself). See id. at 909. Moreover, it
found that Schmeiser “used” the patented gene and cell through the saving
and planting of the seed and the harvesting and selling of the plants
containing the patented cells and genes, thus infringing the patent. See id. at
918. The dissent, relying on the unpatentability of higher life forms and the
availability of sui generis protection under the Plant Breeders’ Rights Act,
would have allowed Schmeiser’s appeal. See id. at 919-27.
39. Modern bio-techniques have received patent protection in the United
States since the 1980s. See Diamond v. Chakrabarty, 447 U.S. 303 (1980)
(deciding by a marginal majority (5-to-4) that a strain of bacteria, genetically
engineered to consume oil, could be patented); Ex parte Hibberd, 227 U.S.P.Q
(BNA) 443 (Bd. of Pat. App. & Int. 1985) (expanding the scope of what the
Patent and Trademark Office considered patentable biotechnologies from
microorganisms to genetically modified plants); see also TRIPS Agreement,
supra note 14, at art. 27 (requiring members of the WTO to make available
patents for any inventions in all fields of technology and specifically requiring
either patent or sui generis protection for plant varieties); Taylor & Cayford,
supra note 3, at 345. But see Harvard Coll. v. Canada (Comm’r of Patents),
[2002] 4 S.C.R. 45 (Can.) (drawing the line at the patentability of “higher life
forms” and holding that “oncomice” are not patentable). Used for cancer
research, an oncomouse is a genetically altered mouse produced by injecting a
cancer-producing gene, the oncogene, into a fertilized mouse egg. The
oncomouse has been held patentable in much of Europe, Sweden, and the
United States. See generally Kirin-Amgen, Inc. v. Hoechst Marion Roussel
Ltd, [2004] UKHL 46 (U.K.) (discussing the extent—and limits—of protection
available to biotechnological product patents and, in particular, a “product-byprocess” claim).
40. See Service Centre for Development Cooperation, supra note 7
(estimating that in 2003 the annual value of seed trade was thirty billion
dollars).
41. See Taylor & Cayford, supra note 3, at 406 (stating that in the United
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companies have clamped down on the rights to save, share,
exchange, and sell seeds produced from cultivation,42 a sobering
thought given the pressure43 developing countries are under to
implement systems for the protection of intellectual property
rights in terms of their obligations as World Trade
Organization (WTO) members.44 Protection of higher life forms
by way of patent is, in any event, fraught with conceptual
difficulties:
Because higher life forms can reproduce by themselves, the grant of a
patent over a plant, seed or non-human animal covers not only the
particular plant, seed or animal sold, but also all its progeny
containing the patented invention for all generations until the expiry
of the patent term. . . . [G]ranting the patent holder exclusive rights
that extend not only to the particular organism embodying the
invention but also to all subsequent progeny of that organism
represents a significant increase in the scope of rights offered to
patent holders. It also represents a greater transfer of economic
interests from the agricultural community to the biotechnology
industry than exists in other fields of science.45

Plant genetic resources for food and agriculture are the
subject of numerous international instruments. The CBD,
reinforced by the International Treaty on Plant Genetic
Resources for Food and Agriculture (ITPGR),46 vests control
and access to genetic resources with national governments of
the country of origin.47 On the other hand, the TRIPS
States “[o]f the 2,247 agricultural biotechnology patents that were issued from
1975 to 1998, 525 were issued or assigned to universities or public
institutions, 812 were issued or assigned to small firms or individuals, and 970
were issued or assigned to corporations”).
42. See, e.g., Monsanto Canada, Inc. v. Schmeiser, [2004] S.C.R. 902
(Can.); GM Company Sues Soy “Seed Saver” for Piracy, CAPE TIMES, Jan. 20,
2005.
43. Although strictly speaking, patents are only enforceable in the issuing
country, the United States is nonetheless able to put pressure on developing
countries to adopt strong intellectual property regimes. See generally Taylor
& Cayford, supra note 3, at 365 (identifying at least three ways in which U.S.
foreign policy exerts pressure: “implementation of the TRIPS Agreement,
support for international harmonization and strengthening of patent law
beyond what is required by TRIPS, and the use of trade agreements and trade
sanctions to both protect U.S. intellectual property overseas and promote
adoption of strong intellectual property regimes in other countries”).
44. See Mushita & Thompson, supra note 13.
45. CANADIAN BIOTECHNOLOGY ADVISORY COMM., PATENTING OF HIGHER
LIFE FORMS AND RELATED ISSUES 12 (2002).
46. International Treaty on Plant Genetic Resources for Food and
Agriculture, Nov. 3, 2001 [hereinafter ITPGR].
47. See Convention on Biological Diversity, supra note 15.
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Agreement, which harmonizes intellectual property rights,
obliges some form of intellectual property protection for plant
species, thereby creating a mechanism for privately-owned
control of access to genetic resources.48 Although African
countries are under pressure to implement, in domestic law,
strong intellectual property rights akin to that of countries
such as Canada and the United States, such rights, in many
instances, appear to be inappropriate for Africa. In addition,
implementation of these rights is not required by international
law, as will be explained below.
Countries in southern Africa are members of the WTO and
are also signatories to the CBD49 and its Cartagena Protocol on
Biosafety.50 In addition, southern African countries are likely
to sign the ITPGR. South and southern Africa are therefore
obliged to implement the provisions of the TRIPS Agreement as
well as the principles in the CBD and the Cartagena Protocol.51
A discussion of significant aspects of these major international
and regional instruments follows.
A. THE CBD AND ASSOCIATED INTERNATIONAL ENVIRONMENTAL
LAW INSTRUMENTS
The CBD came into effect in December 1993, and has as its
objectives the conservation of biological diversity, and the
sustainable use and fair and equitable sharing of the benefits
arising out of the use of genetic resources.52 The CBD also
recognizes “that economic and social development and poverty
eradication are the first and overriding priorities of developing
countries.”53
On environmental and biosafety issues, the Cartagena
Protocol on Biosafety provides an international regulatory
framework for the “environmentally sound” application of
48. See TRIPS Agreement, supra note 14.
49. The CBD was signed by 150 government leaders at the 1992 Rio Earth
Summit. See Convention on Biological Diversity, supra note 15.
50. See CARTAGENA PROTOCOL, supra note 5.
51. Mushita & Thompson, supra note 13 (considering the debate about
intellectual property, particularly in agriculture, in southern Africa and the
alternative approach to TRIPS—the African Model Law for the Protection of
the Rights of Local Communities, Farmers and Breeders, and for the
Regulation of Access to Biological Resources, encompassing the principles of
the CBD and acknowledging and protecting farmer and local community
rights).
52. See Convention on Biological Diversity, supra note 15, at art. 1.
53. Id. at pmbl.

COLLIER FINAL

540

6/7/2006 6:29:21 PM

MINN. J.L. SCI. & TECH.

[Vol. 7:2

biotechnology insofar as it prescribes levels of protection for the
transfer, handling, and use of living modified organisms
resulting from modern biotechnology.54 Moreover, a party may
take into account socio-economic considerations, especially with
regard to indigenous and local communities in reaching a
decision on import under the protocol.55
The CBD deals incisively with indigenous knowledge and
requires that members, subject to national legislation:
[R]espect, preserve and maintain knowledge, innovations and
practices of indigenous and local communities embodying traditional
lifestyles relevant for the conservation and sustainable use of
biological diversity and promote their wider application with the
approval and involvement of the holders of such knowledge,
innovations and practices and encourage the equitable sharing of the
benefits arising from the utilization of such knowledge, innovations
and practice.56

On the issue of control, the CBD provides that “States have
. . . the sovereign right to exploit their own resources.”57 It is
therefore up to individual states to regulate access to genetic
resources.58 The CBD requires that access shall be subject to
the “prior informed consent”59 of the country providing such
resources and “shall be on mutually agreed terms.”60 Member
states are required also to implement legislative,
administrative, or policy measures that have “the aim of
sharing in a fair and equitable way the results of research and
development and the benefits arising from the commercial and
other utilization of genetic resources with the Contracting
Party providing such resources . . . upon mutually agreed
terms.”61
The flipside of access to plant genetic resources is access to
and transfer of technology, particularly biotechnology. The
CBD provides that parties shall implement measures to
provide access to and transfer of technology, particularly to
developing countries that provide the plant genetic resources,
including technology protected by patents and other
54.
55.
56.
57.
58.
59.
60.
61.

See CARTAGENA PROTOCOL, supra note 5, at art. 1.
See id. at art. 26.
Convention on Biological Diversity, supra note 15, at art. 8(j).
Id. at art. 3.
See id. at art. 15(1).
Id. at art. 15(5).
Id. at art. 15(4).
See id. at art. 15(7).
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intellectual property rights, subject to national legislation and
international law.62
Additional safeguards with respect to plant genetic
resources specifically for food and agriculture are put in place
by the ITPGR, which is closely linked to the CBD.63 The
ITPGR seeks to regulate the conservation and sustainable use
of plant genetic resources specifically for agriculture and food
security, as well as the fair and equitable sharing of the
benefits arising out of such use through a multilateral system
of access and benefit-sharing.64 One of the crucial differences
between the CBD and the ITPGR is the reliance, in the CBD,
on individually negotiated bilateral agreements between
parties,65 whereas the ITPGR establishes a multilateral
(worldwide) system of exchange of plant genetic resources, even
though the multilateral system only applies to listed crops. 66
The ITPGR prohibits intellectual property rights over
material obtained through the multilateral exchange, although
it does not necessarily prohibit intellectual property protection
The international agreement
over derivatives thereof.67
requires member states to protect traditional knowledge with
regard to plant genetic resources for food and agriculture, and
to protect the rights of farmers to save, use, exchange, and sell
farm-saved seed or propagating material, subject to national
law.68 As mentioned above, insofar as access to and control
over plant genetic resources are concerned, the agreement
establishes a multilateral system of access and benefit-sharing
covering the plant genetic resources for food and agriculture
listed in Annex I to the agreement.69

62. See Convention on Biological Diversity, supra note 15, at pmbl.
63. See ITPGR, supra note 46, at art. 1.2.
64. See id. at art. 1.1. The treaty lists numerous crops covered under the
multilateral system, including oat, beet, chickpea, citrus, coconut, carrot,
yams, strawberry, sunflower, barley, sweet potato, lentil, apple, cassava,
banana, rice, beans pea, rye, potato, eggplant, sorghum, wheat, and maize.
See id. at annex I.
65. See generally Convention on Biological Diversity, supra note 15.
66. See ITPGR, supra note 46, at pmbl. (explaining that “states may
mutually benefit from the creation of an effective multilateral system for
facilitated access to a negotiated selection of . . . resources”).
67. See id. at art. 12.3(d).
68. See id. at art. 9.
69. See id. at pt. IV (establishing the multilateral system of access and
benefit-sharing).
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B. THE TRIPS AGREEMENT
The TRIPS Agreement was signed after the CBD entered
into force and has a very different agenda. TRIPS is motivated
by international trade and economic law and aims to reduce
impediments to international trade by requiring member states
to provide adequate (universal) standards of trade-related
intellectual property rights.
The TRIPS Agreement is silent on indigenous knowledge,
thereby leaving the door open to the abuse and
misappropriation of traditional and indigenous knowledge,70
unless its provisions are interpreted subject to the CBD and its
associated agreements. The problem is in foreign domestic law
environments where countries are not signatories to the CBD,
for example the United States or where patent offices do not
actively evaluate patents. A recent encouraging development
in the European Patent Office saw the patent office, after a tenyear challenge, uphold a decision to revoke a patent previously
granted on a fungicidal product derived from the seeds of the
Neem tree (Azadirachta indica), an indigenous tree in India,
where the fungicidal properties of the tree had been public
knowledge for centuries.71
Insofar as plant genetic resources are concerned, Article 27
of TRIPS obligates member states to provide for the patenting
of any inventions, whether product or process, “in all fields of
technology, provided they are new, involve an inventive step,
and are capable of industrial application.”72 Although members
may exclude from patentability plants, animals, and biological
processes for the production of plants and animals, members
must provide for the protection of plant varieties either by
70. See generally MONAGLE, supra note 16, at 6. Patents that have relied
upon misappropriated indigenous knowledge include one granted to a Texas
company over rice derived from traditional “Basmati rice” and a patent
granted to the University of Wisconsin over a sweet substance derived from
berries of a plant (Pentadiplandra brazzeana) from Gabon. See id.
71. See Vir Singh, India Wins Seminal Case Against Patent Relating to
Traditional Indian Knowledge, 69 PAT. TRADEMARK & COPYRIGHT J. 543
(2005). A patent that had been granted to the U.S. Department of Agriculture
and the firm W.R. Grace for a method of extraction of oil from the Neem tree
was revoked by the European Patent Office. See Decision Revoking European
Patent No. 0436257 (Feb. 13, 2000). Nonetheless, at least one Neem tree
patent remains in force in the United States. See Margo A. Bagley, Patently
Unconstitutional: The Geographical Limitation on Prior Art in a Small World,
87 MINN. L. REV. 679, 680-82 (2003).
72. TRIPS Agreement, supra note 14, at art. 27(1) (emphasis added).
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patent or by an effective sui generis system.73 A proliferation of
patents appears to have come about in recent years,74
frustrating access to information required, not only for
commercial purposes, 75 but also for public interest reasons.
One of the objectives of the TRIPS Agreement is the
transfer and dissemination of technology.76 TRIPS anticipates
that this objective will take place via the protection of
intellectual property rights,77 although TRIPS does contain
flexibilities for access to technology.78 But what TRIPS gives,
TRIPS, or at least pressure from developed world trading
partners,79 takes away: “Members may provide limited
exceptions to the exclusive rights conferred by a patent,
provided that such exceptions do not unreasonably conflict with
a normal exploitation of the patent and do not unreasonably
prejudice the legitimate interests of the patent owner.”80
Members may “adopt measures necessary to protect public
health and nutrition, and to promote the public interest in
sectors of vital importance to their socio-economic and
technological development, provided that such measures are
73. See id. at art. 27(3)(b). One such sui generis system is that which is
protected under the International Union for the Protection of New Varieties of
Plants (UPOV), based on the International Convention for the Protection of
New Varieties of Plants, Dec. 1, 1961 (revised on Nov. 10, 1972, Oct. 23, 1978,
and
Mar.
19,
1991),
available
at
http://www.upov.int/en/publications/conventions/1961/act1961.htm.
74. See Taylor & Cayford, supra note 3, at 406 (documenting databases on
the issuance of patents that indicate “[t]he number of patents in . . . two
classes [(Chemistry: Molecular Biology and Microbiology; Multicellular Living
Organisms and Unmodified Parts Thereof and Related Processes)], closely
related to plant biotechnology, has increased almost ninefold since 1981.”).
According to Taylor and Cayford, “[i]n the same amount of time, overall utility
patents per year slightly more than doubled.” Id.
75. See id. at 349 (explaining that proliferation of patents results in a socalled “patent thicket” around biotechnology, making access to technology
difficult and expensive). A patent thicket is “an overlapping set of patent
rights requiring that those seeking to commercialize new technology obtain
licenses from multiple patentees.” Id. (quoting Carl Shapiro, Navigating the
Patent Thicket: Cross-Licenses, Patent Pools, and Standard-Setting, in
INNOVATION POL’Y & THE ECON. 119, 120 (Adam Jaffe et al. eds., 2001)).
76. See TRIPS Agreement, supra note 14, at art. 7.
77. See id.
78. See id. at arts. 8, 30-31, 40, 66.
79. See Taylor & Cayford, supra note 3, at 371 (asserting that “the United
States uses its current leverage in trade negotiations, as well as trade
sanctions and tariff benefits, to press observance of U.S. intellectual property
rights in other countries and to seek adoption of patent regimes that go
beyond what is required by TRIPS”).
80. TRIPS Agreement, supra note 14, at art. 30.
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consistent with the provisions of . . . [the TRIPS] Agreement.”81
Members may also provide for compulsory licenses in certain
circumstances.82 These provisions arguably give TRIPS the
flexibility to ensure a level of protection of indigenous or local
communities and plant genetic resources comparable to the
CBD. The reality, however, is that this protection will not
happen because of uneven trading powers, the limited
resources available to Africa,83 and the fact that Africa appears
to be easily seduced by technology.
Article 27(3)(b) of the TRIPS Agreement, which requires
intellectual property protection for plant varieties, provides for
a review of the provision four years from the date of entry into
The
force.
This scheduled review is now overdue.84
submissions from the African Group in this regard can be
summarized as follows:
 There is a likelihood that the intellectual property
protection required for plant varieties could
negatively impact food security and exacerbate
poverty.85
 There is a lack of international mechanisms to deal
with the misappropriation of genetic resources and
traditional knowledge from developing countries.86
 The patenting of life forms is abhorrent to African
tradition and culture.87
81. Id. at art. 8.
82. See id. at art. 31 (explaining that in some instances, members may
allow for the use of “the subject matter of a patent without the authorization
of the right holder,” as long as certain provisions enumerated of the TRIPS
Agreement are respected).
83. Many African countries do not have properly functioning intellectual
property regimes, and are not in a position to sway the balance in favor of
their communities’ best interests.
84. See Taking Forward the Review of Article 27.3(b) of the TRIPS
Agreement – Joint Communication from the African Group, at 1, WTO Doc.
IP/C/W/404 (June 26, 2003) [hereinafter Review of Article 27.3(b)] (noting that
the review was to have been finalized by December 2002).
85. See id. at 3-4 (warning that although the “legitimate rights of
commercial plant breeders should be protected, these should be balanced
against the needs of farmers and local communities”).
86. See id. at 4-5 (cautioning against a “wait and see” attitude and urging
the WTO to seek its own measures to protect against the misappropriation of
genetic resources and traditional knowledge). In light of its various concerns,
the African Group has drafted a Decision on Traditional Knowledge containing
its recommended measures, which it urges the WTO to adopt. See id. at 6-9.
87. See id. at 2 (noting that these “patents are contrary to the moral and
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The African Group implores its members not to derogate
from the provisions of the CBD and the ITPGR, and it also
encourages its members to explore ways to accommodate these
environmental law instruments.88 To this extent, the African
Group favors the adoption by African states of the African
Model Legislation for the Protection of the Rights of Local
Communities, Farmers and Breeders, and for the Regulation of
Access to Biological Resources (African Model Law),89
particularly in relation to a sui generis system for the
protection of plant varieties.90
Insofar as regulating indigenous knowledge and access to
plant genetic resources is concerned, the African Group
discusses the potential use of Article 29 of the TRIPS
Agreement to modify rights and obligations created by the
Article 29, titled
substantive provisions of TRIPS.91
“Conditions on Patent Applicants,” provides for disclosure of
information by the applicant. The African Group suggests
adding the following provision: “Members shall require an
applicant for a patent to disclose the country and area of origin
of any biological resources and traditional knowledge used or
involved in the invention, and to provide confirmation of
compliance with all access regulations in the country of
origin.”92
In addition to the international instruments dealt with
above, there are a number of regional arrangements that could
influence domestic law. Regional arrangements arise out of
bodies such as the African Union (AU) (formerly the
Organization for African Unity (OAU)),93 as well as
geographically defined organizations such as the Southern
African Development Community (SADC)94 and the Economic
cultural norms of many societies in Members of the WTO . . . [and many
Members] consider patents on life forms to be contrary to the fabric of their
society and culture, and to be immoral”).
88. See id.
89. See Review of Article 27.3(b), supra note 84, at 2-3.
90. See id. at 3.
91. See id. at 6.
92. Id. at 6; cf. Patents Amendment Bill, 2005, Bill 17B-05 s. 2 (GA)
(containing similar provisions).
93. See African Union, African Union in a Nutshell,
http://www.africa-union.org/root/au/AboutAu/au_in_a_nutshell_en.htm
(last
visited Feb. 25, 2006).
94. Angola,
Zambia,
Malawi, Namibia, Botswana, Zimbabwe,
Mozambique, South Africa, Lesotho, Swaziland, Democratic Republic of
Congo, United Republic of Tanzania, and Mauritius are members of the
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Community of West African States (ECOWAS).95 A number of
English-speaking African countries, excluding South Africa, are
also members of the African Regional Industrial Property
Organization (ARIPO).96 A protocol adopted in 1982 allows the
ARIPO office to grant patents and register designs on behalf of
its member states.97 Its provisions, however, are flawed
because the office lacks appropriate resources, and its staff
lacks the requisite skills and expertise.
The former OAU drafted two model laws—the African
Model Law and the OAU Model Law on Safety in
Biotechnology. These model laws have the potential to have an
impact on the domestic regulation of biotechnology, indigenous
knowledge, control, access, and benefit-sharing in plant genetic
resources.
C. THE AFRICAN MODEL LAW
The African Model Law provides Africa with “a legislative
means to overcome the inequities of TRIPS,”98 and
acknowledges that local communities possess certain rights
over their biological resources and the technologies that have
evolved over generations and are a priori rights of a collective
nature that take precedence over rights based on private
SADC. See Southern African Development Community, SADC Profile,
http://www.sadc.int/english/about/profile/index.php (last visited Feb. 20, 2006).
95. ECOWAS was formed in 1975 and has fifteen countries on its current
membership list: Benin, Burkina Faso, Cape Verde, Côte d'Ivoire, Gambia,
Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Niger, Nigeria, Senegal, Sierra
Leone, and Togo.
See Economic Community of West African States,
http://www.ecowas.info (last visited Feb. 20, 2006).
96. There are currently fifteen members of ARIPO: Botswana, the
Gambia, Ghana, Kenya, Lesotho, Malawi, Mozambique, Sierra Leone,
Somalia, Sudan, Swaziland, Tanzania, Uganda, Zambia, and Zimbabwe. See
African Regional Industrial Property Organization, Membership and
Advantages, http://www.aripo.wipo.net/membership.html (last visited Feb. 20,
2006). ARIPO is intended for the “study and promotion of and co-operation in
industrial property matters.” Agreement on the Creation of the African
Regional Industrial Property Organization (ARIPO), Dec. 9, 1976, pmbl.,
available at http://www.wipo.int/clea/doc_new/en/zz/zz001en.html.
The
objectives of ARIPO include the promotion of “the harmonization and
development of the industrial property laws, and matters related thereto,
appropriate to the needs of its members and of the region as a whole.” Id. at
art. III(a) (emphasis added).
97. See Protocol on Patents and Industrial Designs Within the Framework
of the African Regional Industrial Property Organization (ARIPO), Dec. 10,
1982, § 1, available at http://www.wipo.int/clea/docs_new/en/zz/zz004en.html.
98. Mushita & Thompson, supra note 13, at 77.
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interests.99 The African Model Law seeks to implement the
relevant provisions of the CBD100 and applies to biological
resources in both in situ and ex situ conditions, derivatives of
biological resources, community knowledge and technologies,
local and indigenous communities, and plant breeders.101
Access to such biological resources, knowledge, or technologies
of local communities is granted by submitting an application
for prior informed consent and a written permit.102 The
application to the National Competent Authority103 must
disclose the full details of the project for which the resource is
required, including the purpose for which access to the resource
is requested, the risks to biological diversity, and the proposed
mechanisms and arrangements for benefit-sharing.104 The
sharing of benefits based upon customary practices of local
communities does not apply to “any person or persons not living
in the traditional and customary way of life.”105
Prior informed consent is also required from the concerned
local community, including its female members.106 An access
permit is granted through a signed written agreement among
the three parties: the National Competent Authority, the
community or communities concerned, and the applicant or
collector.107 The contents of this tripartite agreement are
regulated by Article 8 of the African Model Law. Specifically,
99. See African Model Legislation for the Protection of the Rights of Local
Communities, Farmers and Breeders, and for the Regulation of Access to
Biological Resources (2000), pmbl. [hereinafter African Model Law], available
at http://www.grain.org/brl_files/oau-model-law-en.pdf.
100. See id. (stating that “there is a need to implement the relevant
provisions of the Convention on Biological Diversity”).
101. Id. at art. 2(1). The legislation, however, does not affect the
“traditional systems of access, use or exchange of biological resources.” Id. at
art. 2(2)(i).
102. See id. at art. 3(1).
103. The “National Competent Authority is the entity authorized by the
State to supervise and watch over the implementation of one or more of the
components of the present law.” Id. at art. 1.
104. See African Model Law, supra note 99, at art. 4. A formula for
“benefit-sharing” is provided for by Article 12 of the African Model Law. In
addition to a share of the actual earning derived from the biological resource
or knowledge, a “permit fee” is also payable, in advance, based on “whether or
not the collection is to be used for commercial purposes, and the number of
samples, the area of collecting, the duration of collection and whether or not
the collector is granted exclusive rights.” Id. at art. 12(1).
105. Id. at art. 2(3).
106. See id. at art. 5(1).
107. See id. at art. 7(2).
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the agreement requires the collector to contribute financially to
the efforts of the state and communities concerned in the
regeneration and conservation of the biological resource. The
collector may only apply for intellectual property protection of
the biological resource, or parts or derivatives thereof, or for
community knowledge or technology with the additional prior
informed consent of the original providers. Article 9 then goes
on to provide that patents over life forms and biological
processes will not be recognized and cannot be applied for, but
does provide for plant breeders’ rights.
The African Model Law recognizes and protects community
rights,108 farmers’ rights,109 and plant breeders’ rights,110 and
calls into question the suitability of intellectual property
protection systems, particularly patent law, for developing
countries where the main concern is often to secure food and to
fight poverty.111
D. THE OAU MODEL LAW ON SAFETY IN BIOTECHNOLOGY
The OAU Model Law on Safety in Biotechnology,
influenced by the Cartagena Protocol on Biosafety, seeks to
harmonize existing legislation in the area of biosafety. To that
end, it provides a framework of biosafety regulations designed
to protect Africa’s rich biodiversity, along with animal and
human health, from the risks inherent in modern
biotechnology.112
The OAU Model Law on Safety in Biotechnology contains
strict regulations concerning the “import, export, transit,
contained use, release and placing on the market of any GMO
[Genetically Modified Organism] and a product of a GMO,
whether it is intended . . . for use as a pharmaceutical, for food,

108. See id. at pt. IV.
109. See African Model Law, supra note 99, at pt. V.
110. See id. at pt. VI.
111. See Mushita & Thompson, supra note 13, at 79-80 (explaining that
biodiversity, including indigenous plants, serves as a vital source of food and
medicine for the poor, and that the need to protect related intellectual
property rights is often, at most, a secondary priority). See generally ULF
ANDERFELT, INTERNATIONAL PATENT-LEGISLATION AND DEVELOPING
COUNTRIES (1971).
112. MARIAM MAYET, WHY AFRICA SHOULD ADOPT THE OAU AFRICAN
MODEL LAW ON SAFETY IN BIOTECHNOLOGY 1 (2003), available at
http://www.biosafetyafrica.net/_DOCS/CommentBiosafetyModelLaw.pdf.
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feed or processing.”113 Decisions in this regard must be based
on the precautionary principle contained in the CBD. The OAU
Model Law also views “public participation and access to
information as important and indispensable components of
environmental governance.”114
The regional arrangements, the two model laws drafted by
the former OAU, align with the provisions of the CBD and
associated law instruments rather than with the provisions of
the TRIPS Agreement. We shall now consider the route
followed in domestic law in southern Africa, in particular South
Africa.
III. DOMESTIC LAW IN SOUTH AND SOUTHERN AFRICA
Earlier forms of statutory protection for intellectual
property in southern African domestic law merely aimed to
extend the protection afforded to colonial proprietors of
intellectual property. For example, in Botswana the nowrepealed Patents and Designs Protection Act115 aimed to
“provide for the protection in Botswana of inventions the
subject of patents subsisting in the United Kingdom or in the
Republic of South Africa.”116 Some African countries, which are
now members of ARIPO, simply had no industrial property
legislation, though non-statutory provisions were usually made
for unlawful acts relating to intellectual property rights.117
Although the idea of individual ownership of intellectual
property is antithetical to traditional African society and
customary practices, intellectual property laws nonetheless
remained on the statute books after colonial rulers transferred
power to their African successors. African societies’ disfavor of
private intellectual property rights is, however, illustrated by
the activity, or rather inactivity, at industrial property offices
in Africa generally.118 Nonetheless, Africa is duty-bound to
113. Id. at 3.
114. Id. at 9.
115. Chapter 68:02, The Laws of Botswana, Revised Edition 1997. The
Patents and Designs Protection Act commenced on March 11, 1955 and has
now been replaced by the Industrial Property Act 14 of 1996, available at
http://www.tralac.org/pdf/Industrial_Property_Act_Botswana.pdf.
116. Patents and Designs Protection Act of 1955, pmbl.
117. T.D. BURRELL, BURRELL’S SOUTH AFRICAN PATENT AND DESIGN LAW §
1.19.2 (3d ed. 1996) (stating that Ethiopia is an example of one such country).
118. Statistics from the U.N. Development Program and U.S. Patent Office
reflect that in 2001, 2.5 technology patents per one million people in South
Africa, where a fairly sophisticated intellectual property regime is in place,
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implement and enforce the intellectual property rights
prescribed by the TRIPS Agreement.119
In South Africa, a plethora of policy documents and
legislation relating to plant genetic resources for food and
agriculture is in place that appears, on the surface at least, to
comply with the major tenets of both the TRIPS and CBD
agreements. Of significance, and considered below, are the
Patents Act 57 of 1978, the Plant Breeders’ Rights Act 15 of
1976, the Genetically Modified Organisms Act of 1977, and the
National Environmental Management: Biodiversity Act 10 of
2004. It is also useful to consider applicable provisions of the
South African Constitution, as all laws in South Africa must be
interpreted in a manner consistent with the Bill of Rights
contained in the Constitution (and international law must be
considered when interpreting the Bill of Rights).120
A. CONSTITUTION OF THE REPUBLIC OF SOUTH AFRICA ACT 108
OF 1996 (CONSTITUTION)
The Bill of Rights121 in the Constitution of South Africa
provides that everyone has a right of access to sufficient food
and water,122 the right to an environment that is not harmful to
health or well-being, and the right to environmental protection,
for the benefit of present and future generations, through
sustainable development and use of natural resources that also
promotes economic and social development.123 The Bill of
Rights also protects cultural associations.124
compared with twenty-five in Australia and 779 in South Korea. See Alla
Katsnelson, South Africa Fights Low Patent Rate, NATURE.COM, Oct. 14, 2004,
http://www.nature.com/news/2004/041018/full/bioent834.html.
Intellectual
property generally is not a priority in Africa. In Angola, for example, in
twenty-nine years only thirty trademarks were registered over Angolan
industrial products.
See Press Release, Angola Press Agency, Angola
Struggling to Make Inroads into Intellectual Property (Sept. 17, 2004),
available at http://www.tralac.org/scripts/content.php?id=2919.
119. See TRIPS Agreement, supra note 14, at art. 41(1) (stating that
members must provide enforcement mechanisms against infringements of the
TRIPS Agreement). Developing countries were given an extended period of
time to amend domestic law to comply with the TRIPS Agreement. See id. at
art. 65(2).
120. See S. AFR. CONST. 1996 art. 39.
121. Id. at arts. 7-39.
122. See id. at art. 27(1)(b).
123. See id. at art. 24.
124. See id. at art. 31.
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In addition, the Constitution provides that “no one may be
deprived of property except in terms of law of general
application, and no law may permit arbitrary deprivation of
property.”125 Although property is specifically not limited to
land,126 the scope of the property clause is otherwise unclear
and could possibly include immaterial property rights.
However, in In re Certification of the Constitution of the
Republic of South Africa, 1996,127 the Constitutional Court
held, in response to an objection raised regarding the failure to
recognize a right to intellectual property, that it was not
necessary to mention intellectual property separately as a
universally accepted fundamental right in view of the fact that
a right to intellectual property is “rarely recognised in regional
conventions protecting human rights and in the constitutions of
acknowledged democracies.”128 The objection was dismissed.129
The Constitution goes on to provide that:
Property may be expropriated only in terms of law of general
application
a. for a public purpose or in the public interest; and
b. subject to compensation, the amount of which and the time and
manner of payment of which have either been agreed to by those
affected or decided or approved by a court.130

Public interest includes “reforms to bring about equitable
access to all South Africa’s natural resources.”131 If, indeed,
intellectual property is constitutionally protected, it is certainly
possible to regulate “expropriation” for the public good. It is
argued that the principles of “deprivation” and “expropriation”
apply to the vertical relationship between the state and
property owners rather than between private individuals.132
These relationships and the nuances relating to plant genetic
resources have yet to be tested in terms of the Constitution.

125. Id. at art. 25(1). The law of general application is sufficiently broad to
refer to statutory law, common law, and customary law.
126. See S. AFR. CONST. 1996 art. 25(4)(b).
127. 1996 (4) SA 744 (S. Afr.).
128. Id. at 799 (internal citation omitted).
129. See id. at 800.
130. S. AFR. CONST. 1996 art. 25(2). Expropriation is a form of deprivation
for which compensation is received. See P.J. BADENHORST, BILL OF RIGHTS
COMPENDIUM § 3FB4 (1998).
131. S. AFR. CONST. 1996 art. 25(4)(a).
132. BADENHORST, supra note 130, § 3FB16.
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B. PATENTS ACT 57 OF 1978 (PATENTS ACT) AND THE PATENTS
AMENDMENT BILL OF 2005
The Patents Act provides that a patent may be granted for
any new invention involving an inventive step and which is
capable of being used or applied in trade, industry, or
agriculture.133 A patent shall not be granted, however, “for any
variety of animal or plant or any essentially biological process
for the production of animals or plants, not being a micro—
biological process or the product of such a process.”134
Microbiological processes and the resultant products are
patentable.135 While not protected by the Patents Act, certain
plant varieties136 may be protected in terms of the Plant
Breeders’ Rights Act 15 of 1976.
For the purposes of establishing the scope of the
“essentially biological process” exclusions, the Guidelines for
Examiners in the European Patent Office are likely to be
persuasive:
The question whether a process is “essentially biological” is one of
degree depending on the extent to which there is technical
intervention by man in the process; if such intervention plays a
significant part in determining or controlling the result it is desired to
achieve, the process would not be excluded. To take some examples, a
method of crossing, inter-breeding, or selectively breeding, say,
horses, involving merely selecting for breeding and bringing together
those animals having certain characteristics would be essentially
biological and therefore unpatentable. On the other hand, a process
of treating a plant or animal to improve its properties or yield . . .
would not be essentially biological since although a biological process
is involved, the essence of the invention is technical; the same could
apply to a method of treating a plant characterized by the application
of a growth-stimulating substance or radiation. The treatment of soil
by technical means to suppress or promote the growth of plants is also
not excluded from patentability.137

133. See Patents Act 57 of 1978 s. 25(1).
134. Id. at s. 25(4)(b).
135. See id.
Microbiology is defined as “the study of single-celled
organisms too small to be observed with the naked eye. Classically, this field
has included the study of algae and protozoa.” R. WILLIAMS & E. LANSFORD,
ENCYCLOPEDIA OF BIOCHEMISTRY (1st ed. 1967), quoted in BURRELL, supra
note 117, § 1.26.7 n.310.
136. The variety must be one of a plant species prescribed in the
regulations to the Plant Breeders’ Rights Act, although it is possible to apply
to have a plant added to the prescribed list. See Kidd & Mayett, supra note
18, at 239.
137. BURRELL, supra note 117, § 1.26.7 (emphasis added).
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The provisions of the Patents Act, read together with the
Plant Breeders’ Rights Act 15 of 1976, appear to comply with
the relevant provisions of the TRIPS Agreement. Insofar as
compliance with the provisions of the CBD138 regarding
indigenous knowledge, control, and access to plant genetic
resources is concerned, it is necessary to consider the proposed
amendments to the Patents Act contained in the Patents
Amendment Bill, the object of which is to “empower the
registrar of patents to refuse or revoke a patent which is based
on biological material, [and to] refuse, revoke or invalidate a
patent which is based on prior knowledge associated with such
materials.”139 Once amended, the Patents Act will “require an
applicant for a patent to furnish information relating to any
role played by an indigenous biological resource, a genetic
resource or traditional knowledge or use in an invention.”140
More specifically, the Bill amends the Act by inserting the
following provisions:
(3A) Every applicant who lodges an application for a patent . . . shall .
. . lodge with the registrar a statement in the prescribed manner
stating whether or not the invention for which protection is claimed is
based on or derived from an indigenous biological resource, genetic
resource, or traditional knowledge or use.
(3B) The registrar shall call upon the applicant to furnish proof in the
prescribed manner as to his or her title or authority to make use of
the indigenous biological resource, genetic resource, or of the
traditional knowledge or use if an applicant lodges a statement that
acknowledges that the invention for which protection is claimed is
based on or derived from an indigenous biological resource, genetic
resource, or traditional knowledge or use.141

These amendments bring the Patents Act in line with the
National Environmental Management Biodiversity Act, which
incorporates the provisions of the CBD and the Bonn
Guidelines regarding benefit-sharing schemes in relation to
genetic resources and traditional knowledge used in patent
inventions.142

138. See also National Environmental Management: Biodiversity Act 10 of
2004.
139. Memorandum on the Objects of the Patents Amendment Bill s. 4.1(a),
Patents Amendment Bill, 2005, Bill 17B-05 (GA).
140. Patents Amendment Bill, 2005, Bill 17B-05 pmbl. (GA).
141. Id. at s. 2.
142. See generally National Environmental Management: Biodiversity Act
10 of 2004 s. 83.
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C. PLANT BREEDERS’ RIGHTS ACT 15 OF 1976 (PLANT BREEDERS’
ACT)
The Plant Breeders’ Act provides “for a system whereunder
plant breeders’ rights relating to varieties of certain kinds of
plants may be granted and registered”143 and essentially
corresponds with the model offered by the International Union
for the Protection of New Varieties of Plants (UPOV), hence
meeting South Africa’s obligations arising out of Article 27(3)(b)
of the TRIPS Agreement.
The Plant Breeders’ Act does not require the prior
informed consent of affected communities and does not provide
for material transfer or benefit-sharing agreements.144 A plant
breeder’s right is granted for twenty-five years with respect to
vines and trees and twenty years for everything else.145 During
the currency of the protection, a license is required for:
(a) production or reproduction (multiplication);
(b) conditioning for the purposes of propagation;
(c) sale or any other form of marketing;
(d) exporting;
(e) importing;
(f) stocking for any of the purposes referred to in paragraphs (a) to (e),
of –
(i) propagating material of the relevant variety; or
(ii) harvested material, including plants, which was obtained
through the unauthorized use of propagating material of the relevant
variety.146

However, where a person has procured propagating
material of a protected variety in a legitimate matter, it shall
not be an infringement to resell the propagating material or
any plant or product derived from the propagating material, or
to use or multiply the propagating material in the development
of a different variety.147 Neither is it an infringement to use
the propagating material for bona fide research or private or
non-commercial purposes,148 nor where the person who
143.
144.
145.
146.
147.
148.

Plant Breeders’ Act 15 of 1976 pmbl.
See generally Plant Breeders’ Act 15 of 1976.
Id. at s. 21.
Id. at s. 23(1).
See id. at s. 23(6)(a)-(c).
See id. at s. 23(6)(d)-(e).
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acquires the material is a farmer who uses harvested material
obtained on land occupied by him from the propagating
material for purposes of propagation, provided that the
harvested material shall not be used for propagation by any
person other than that farmer.149 Sections 26 and 27 of the
Plant Breeders’ Act provide mechanisms and principles for the
application for and granting of a compulsory license to deal
with a protected plant variety where the holder of a plant
breeder’s right has unreasonably refused to grant a license or
has imposed unreasonable conditions.
D. GENETICALLY MODIFIED ORGANISMS ACT 15 OF 1997 (GMO
ACT)
The GMO Act is the key biosafety law in South Africa, and
on its face, is not concerned about indigenous knowledge and
control and access to plant genetic resources. Instead, the
GMO Act seeks:
To provide for measures to promote the responsible development,
production, use and application of genetically modified organisms; to
ensure that all activities involving the use of genetically modified
organisms (including importation, production, release and
distribution) shall be carried out in such a way as to limit possible
harmful consequences to the environment; to give attention to the
prevention of accidents and the effective management of waste; to
establish common measures for the evaluation and reduction of the
potential risks arising out of activities involving the use of genetically
modified organisms; to lay down the necessary requirements and
criteria for risk assessments; to establish a council for genetically
modified organisms; to ensure that genetically modified organisms
are appropriate and do not present a hazard to the environment; and
to establish appropriate procedures for the notification of specific
activities involving the use of genetically modified organisms; and to
provide for matters connected therewith.150

What is of concern, and ultimately impacts control and
access to plant genetic resources, is the lack of public
participation and lack of access to information provided for by
the GMO Act.151 This is exacerbated by the lack of regulations
with respect to labeling of genetically modified products.152

149. See id. at s. 23(6)(f).
150. Genetically Modified Organisms Act 15 of 1997 pmbl.
151. See MARIAM MAYET, CRITICAL ANALYSIS OF PERTINENT LEGISLATION
REGULATING GENETIC MODIFICATION IN FOOD AND AGRICULTURE IN SOUTH
AFRICA 20-39 (2001).
152. Labeling of foodstuffs is currently regulated by the Foodstuffs,
Cosmetics and Disinfectants Act 54 of 1972 s. 5.
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Numerous decisions taken under the GMO Act have been
subjected to appeal,153 and the lack of access to information
has, on at least one occasion, resulted in litigation in the High
Court of South Africa. In Trustees for the Time Being of the
Biowatch Trust v. Registrar: Genetic Resources,154 Biowatch
South Africa, a small environmental organization, approached
the High Court to compel the government to disclose
information about genetically modified crops entering South
Africa and being grown in South Africa.155 Although Biowatch
was largely successful in the application, a costs order was
granted against Biowatch in favor of Monsanto,156 an action
that could potentially cripple the organization, notwithstanding
the fact that it had been Monsanto’s choice to be joined in the
litigation.
Amendments to the GMO Act have been proposed to
incorporate provisions of the Cartagena Protocol on
Biosafety.157 The amendments have, however, been criticized
for a failure, again, to allow for adequate public participation
and information sharing, and also for failing to adopt a policy
in line with the precautionary approach.158
E. NATIONAL ENVIRONMENTAL MANAGEMENT: BIODIVERSITY
ACT 10 OF 2004 (BIODIVERSITY ACT)
One of the objectives of the Biodiversity Act is “to give
effect to ratified international agreements relating to

153. For example, in 2004’s Trustees for the Time Being of the Biowatch
Trust v. Syngenta Seed Co. (PTY), Biowatch South Africa lodged an
unsuccessful appeal with the Appeal Board, in terms of the GMO Act, against
a decision of the Executive Council for GMOs granting authorization to
Syngenta Seed to import, release, and conduct field trials pertaining to Bt 11
maize in South Africa under particular conditions. See Melanie Gosling,
Biowatch Loses Appeal Against GM Maize Company, MERCURY, Dec. 27, 2004,
available
at
http://www.themercury.co.za/index.php?fSectionId=283&fArticleId=2355874.
154. No. 23005/2002 (High Ct. S. Afr. (Transvaal Provincial Div.) Feb. 23,
2005).
155. See id. at 10-20.
156. See id. at 61-65.
157. Genetically Modified Organisms Amendment Bill, 2004, Bill 26848
pmbl. (GA).
158. See JERRY BOLTINA, PORTFOLIO COMM. ON AGRIC. AND LAND AFFAIRS,
SUBMISSION ON GENETICALLY MODIFIED ORGANISMS AMENDMENT BILL 1-3
(2005).
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biodiversity which are binding on the Republic.”159
Accordingly, the Biodiversity Act aims to provide for the
“sustainable use of indigenous biological resources; [and] the
fair and equitable sharing of benefits arising from
bioprospecting involving indigenous biological resources.”160
From the subsequent wording of the Biodiversity Act it would
appear that the “international agreements” referred to include
both the CBD and the ITPGR.
Chapter 6 of the Biodiversity Act deals with
bioprospecting, access, and benefit-sharing related to
indigenous biological resources.161 Specifically excluded from
the operation of Chapter 6 are: (1) genetic material of human
origin, (2) any exotic animals, plants, or other organisms,162
and (3) indigenous biological resources listed in terms of the
ITPGR.163
Persons who wish to “engage in bioprospecting involving
any indigenous biological resources” or “export from the
Republic any indigenous biological resources for the purpose of
bioprospecting or any other kind of research” are required to
obtain a permit.164 The authority that issues the permit is
required to protect any interests that the following
stakeholders may have in the bioprospecting project:
159. See National Environmental Management: Biodiversity Act 10 of 2004
s. 2(b).
160. Id. at pmbl. Bioprospecting involves “any research on, or development
or application of, indigenous biological resources for commercial or industrial
exploitation, and includes – (a) the systematic search, collection or gathering
of such resources.” Id. at s. 1.
161. “Indigenous biological resources” is defined to include “(i) any living or
dead animal, plant or other organism of an indigenous species; (ii) any
derivative of such animal, plant or other organism; or (iii) any genetic material
of such animal, plant or other organism.” Id. at s. 1. When used in relation to
bioprospecting, indigenous biological resources include the above “whether
gathered from the wild or accessed from any other source, including any
animals, plants or other organisms of an indigenous species cultivated, bred or
kept in captivity or cultivated or altered in any way by means of
biotechnology; and any cultivar, variety, strain, derivative, hybrid or fertile
version [derived therefrom].” Id. at s. 80(2)(a)(i-ii). When used in relation to
bioprospecting, indigenous biological resources also include “any exotic
animals, plants or other organisms, whether gathered from the wild or
accessed from any other source which, through the use of biotechnology, have
been altered with any genetic material or chemical compound found in any
indigenous species or any [other indigenous resources].” Id. at s. 80(2)(a)(iii).
162. Except those referred to in section 80(2)(a)(iii) of the National
Environmental Management: Biodiversity Act 10 of 2004.
163. See id. at s. 80(2)(b).
164. Id. at s. 81(1).
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(a)
A person, including any organ of state or community, providing
or giving access to the indigenous biological resources to which the
application relates; and
(b)

an indigenous community ——

(i)
whose traditional uses of the indigenous biological resources
to which the application relates have initiated or will contribute to or
form part of the proposed bioprospecting; or
(ii) whose knowledge of or discoveries about the indigenous
biological resources to which the application relates are to be used for
the proposed bioprospecting.165

In the event that a stakeholder has an interest, a permit
may be issued only if the applicant has disclosed all material
information to the stakeholder and thereafter obtained the
prior consent of the stakeholder.166 In addition, the applicant
and the stakeholder must enter into a material transfer
agreement regulating access to the resources, and a benefitsharing agreement that the stakeholder share in future
benefits derived from the bioprospecting.167 The Minister
responsible for national environmental management must
approve
the
material
transfer
and
benefit-sharing
agreements.168 The principles for benefit-sharing and material
transfer agreements are set out in the Biodiversity Act.169
One example of a benefit-sharing model in South Africa is
the agreement—entered into before the Biodiversity Act
became operative—between the San communities and the
Council for Scientific and Industrial Research (CSIR) with
respect to the indigenous Hoodia cactus that has chemical
For centuries,
properties useful for fighting obesity.170
indigenous communities have chewed on the Hoodia leaf as an
Since 1986, the CSIR has filed
appetite suppressant.171
worldwide patents with respect to a method of obesity control
that uses the chemical composition of the Hoodia plant and has
subsequently negotiated a benefit-sharing agreement with the
owners of the traditional knowledge.
This agreement
stipulates that the CSIR will pay the San eight percent of the
165. Id. at s. 82(1)(a-b).
166. See id. at s. 82.
167. See id. at s. 82(2)(b).
168. See National Environmental Management: Biodiversity Act of 2004 s.
82(2)(c).
169. See id. at ss. 83-84.
170. See Terblanche, supra note 18, at 61-62.
171. See id. at 61.
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payments it receives from its licensee(s)172 and six percent of all
royalties the CSIR receives once the drug is commercially
available.173
South Africa was the first country on the African continent
to grow genetically modified crops and accordingly, fairly
sophisticated legislation, such as that discussed above, has
resulted. The legislation however has proved to be ineffective
in protecting vulnerable communities and the environment.
This is illustrated in the case of genetically modified cotton
grown in South Africa.174
IV. A CASE IN POINT: GENETICALLY MODIFIED COTTON
IN SOUTH AFRICA
Cotton crops can withstand harsh climates, making cotton
a useful cash crop for farmers in Africa. After the United
States and Uzbekistan, Africa is the third largest cotton export
region in the world,175 and is therefore a target for genetically
modified cotton plants.176 South Africa is currently the only
African country to allow the commercial planting of genetically
modified cotton,177 although field trials are being conducted in
other parts of Africa, including Egypt, Mali, and Burkina
Faso.178
It must be asked, who are the true beneficiaries of
genetically modified cotton crops in South Africa? Much of the
uptake of genetically modified crops in South Africa is in
commercial agriculture, although small-holder farmers are
172. The UK-based botanical pharmaceutical company Phytopharm is one
such licensee. See id.
173. See id. at 62.
174. See ELFRIEDA PSCHORN-STRAUSS, BIOWATCH SOUTH AFRICA, BT
COTTON AND SMALL-SCALE FARMERS IN MAKHATHINI – A STORY OF DEBT,
DEPENDENCY,
AND
DICEY
ECONOMICS,
available
at
http://www.grain.org/research/btcotton.cfm?id=100 (last visited Feb. 25, 2006).
India and China farmers have followed suit. See id.
175. See GREENBERG, supra note 31, at 4.
176. The purported benefit of Bt cotton is that the need for insecticides
should decrease because the insecticide is built into the genetic structure of
the plant. See id. This should result in reduced cost to the farmer and
reduced environmental damage.
177. See PSCHORN-STRAUSS, supra note 174. It is estimated that eighty
percent of the cotton grown in South Africa is genetically engineered.
ELFRIEDA PSCHORN-STRAUSS, BIOWATCH SOUTH AFRICA, BRIEFING NO. 2:
WHAT IS SOUTH AFRICA DOING ABOUT GENETICALLY ENGINEERED CROPS? 1
(2004), http://www.biowatch.org.za/pubs/briefings/2004/briefing02.pdf.
178. See GREENBERG, supra note 31, at 20-21.
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being encouraged to plant genetically modified crops. This
encouragement came after a “successful” pilot project in
Makhathini that has been touted by multinational
agribusinesses throughout Africa and beyond.179
Although it is assumed that biotechnology in agriculture
would be introduced predominantly through public institutions
and processes,180 this is not necessarily so. In 1997, the Bt
cotton plant, sold as Bollgard®, was introduced to the
Makhathini Flats in northern Kwa-Zulu Natal by Monsanto
and Delta Pine, supported by public institutions such as the
Department of Agriculture, and supported financially by
Vunisa Cotton, a private company, and the Land Bank, a
government bank.181 It would appear from the report by
Elfrieda Pschorn-Strauss that the biosafety trials, which should
have been conducted two or three years before the release of
the plant to farmers, were conducted almost simultaneously
with its release.182 Nevertheless, the Makhathini project was
hailed a success183 and was used not only as a means to put
pressure on other African countries to adopt genetically
modified crops,184 but also as a moral justification for United
States action against the European Union. The argument is
that Europe’s cautious approach toward genetically modified
food has a detrimental effect on Africa’s potential to fight
poverty and food insecurity.185 The “success” however was
179. Biowatch reports that ”[i]n the 2001/2002 season 300 large-scale
farmers produced 95% of the crop, while 3000 small-scale farmers on the
Makhathini Flats in Northern KwaZulu Natal and in the south-eastern part of
Mpumalanga produced the remaining 5%.” ELFRIEDA PSCHORN-STRAUSS &
CRISTINE JARDINE, BIOWATCH SOUTH AFRICA, BRIEFING NO. 3: GENETICALLY
ENGINEERED
COTTON:
HIGH
RISKS,
LOW
RETURNS
1
(2004),
http://www.biowatch.org.za/pubs/briefings/2004/briefing03.pdf.
180. See Taylor & Cayford, supra note 3, at 335.
181. PSCHORN-STRAUSS & JARDINE, supra note 179, at 3. Vunisa Cotton,
established by Clark Cotton, serves as an agent for seed and agrochemical
companies in the area and also buys back cotton from the farmers after
harvest. See id.
182. See PSCHORN-STRAUSS, supra note 174.
183. Reports by the genetic modification industry indicate that the cotton
yields of the small-holder farmers increased dramatically by up to 220%. See
PSCHORN-STRAUSS, supra note 174. What the reports fail to indicate, among
much else, is the artificial level of support and the package of inputs that
accompanied the seeds. See id.
184. Pressured countries include Uganda, Zambia, and Zimbabwe. See id.
185. See id. A Makhathini farmer has even been used in argument by the
United States in its action at the WTO against the European Union’s labeling
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short-lived, as subsequent floods and droughts left farmers
with staggering debt.186 By all accounts the Makhathini project
is now in tatters.
Farmers were encouraged to purchase Monsanto’s
Bollgard® seed on the basis that the crops would increase the
farmers’ yields and would require reduced insecticide
spraying.187 Additional inputs into the Makhathini project
included a donation from Monsanto of $10,000 to the Ubombo
Farmers Association for the purchase of farming equipment in
2001.188
Farmers who purchased the expensive seed were required
to sign a Monsanto Technology Agreement, in terms of which
they undertook to:
 Use the seed for planting a commercial crop for only
one season;
 Plant a refuge as part of the insect resistance
management strategy;
 Not supply any seed containing Bollgard® to any
third party;
 Not use or provide seed containing Bollgard® to
anyone for crop breeding, research, or seed
production;
 Not ratoon any Bollgard® cotton;
 Allow Monsanto agents to inspect the growers’
fields to ensure that the correct refuge areas have
been planted.189
Pschorn-Strauss ascertained, during a 2001 survey of
twelve farmers who planted Bollgard®, that they did not
understand the contracts they had signed.190 It is even
reported that “farmers understand their contracts to mean that
in the case of a crop failure, the seed will be replaced.”191
Only one of the twelve farmers told Pschorn-Strauss that
he had been fully apprised of the terms of the contract; five of
the twelve were aware of the need to plant refuges and only
three had done so.192 One of the concerns is that responsibility
restrictions for genetically modified products. See id.
186. PSCHORN-STRAUSS & JARDINE, supra note 179, at 3.
187. See PSCHORN-STRAUSS, supra note 174.
188. See id.
189. Id.
190. See id.
191. See id.
192. See id. Moreover:
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for monitoring and risk assessment is not adequately addressed
by the government in South Africa.193 The current legislative
framework would probably allow seed companies to escape
liability for damage.
In addition to the environmental concerns,194 the
Makhathini
project
raises
numerous
socio-economic
concerns.195 At the center of the socio-economic concerns is the
cost of accessing genetically modified crops. The poverty gap
between farmers who are able to afford the technology and
those who are not196 is likely to widen, and the farmers who are
able to access genetically modified crops could become trapped
in a debt-cycle that is far worse than the debt-cycles already
experienced by farmers growing non-genetically modified
crops.197
Access to land is an additional socio-economic and political
concern in post-apartheid South Africa. Currently much of the
area under discussion is predominantly owned by the state and
is held in trust by the Minister of Land Affairs until such time
as it is redistributed to the inhabitants of the area. One of the
issues is whether the land should be redistributed as freehold
land or whether it should become communal land. The
outcome could have major implications for current inhabitants.
Pending the outcome of these deliberations, inhabitants are

The industry has recognised the real possibility of resistance
developing and has made it a contractual requirement that users of
Bt crops plant refuges of non-GE varieties to ensure that a subpopulation of insects is not exposed to Bt toxin. This sub-population
will not develop any resistance and will pass on the non-resistant
gene, diluting the resistant genes coming from insects that have been
exposed to and survived Bt toxin.
PSCHORN-STRAUSS & JARDINE, supra note 179, at 4.
193. PSCHORN-STRAUSS & JARDINE, supra note 179, at 3.
194. There is growing evidence that the benefits, or effectiveness, of
genetically engineered cotton crops decreases over time. In Australia, for
example, one study reports that the pesticide benefits of Monsanto’s
genetically engineered Ingard cotton varieties steadily declined from one
season to the next: “Average use of insecticide . . . was 52% less in 1996/1997
(season of Ingard introduction), 44% less in 1997/1998, and only 38% less in
1998/1999.” Id.
195. See PSCHORN-STRAUSS, supra note 174.
196. Small loans in South Africa are inordinately expensive.
The
microlending industry in South Africa does not adequately address the needs
of small businesses and enterprises and is currently under review. It is likely
that a new National Credit Bill will replace the existing legal infrastructure.
197. See PSCHORN-STRAUSS, supra note 174.

COLLIER FINAL

2006]

6/7/2006 6:29:21 PM

BIOTECHNOLOGY IN SOUTHERN AFRICA

563

reluctant to commit to the land on a long-term basis.
Since the introduction of genetically engineered cotton, it is
reported that the number of cotton varieties available to
farmers has decreased (and available varieties are
predominately genetically engineered198), production has fallen,
the cost has increased, many jobs have been lost, and spinners
have expressed dissatisfaction with the quality of cotton now
being produced.199
CONCLUSION
Attempts to control and regulate access to genetic
resources must be seen in light of the history and context of
agriculture in Africa: “Genetic resources at the local, national,
and international levels, play a critical role in the lives of all
Africans. The most obvious aspect of this is food.”200
Africa should be cautious in its approach to modern
biotechnology applications in agriculture for it may not hold the
solutions that Africa seeks. Rather, an introspective approach
to agriculture is necessary. Namely, agriculture in Africa
needs to be considered in the broader historical, social,
economic, and political context of the continent. While it might
be difficult to influence global policy to prevent the anomalies,
such as the misappropriation of indigenous knowledge,
occurring in developed countries, at least domestic law in
Africa can remain true to the interests of its communities and
the principles of international environmental law. To some
extent the law in South Africa mirrors the principles of the
CBD, while still implementing the provisions of TRIPS. The
law in South Africa, however, has major pitfalls, insofar as
public participation, awareness (for example, labeling), and the
best interest of its people are concerned.
It should not be forgotten that it is the genetic resources of
indigenous plants themselves, and not access to global markets,
which can provide Africa with food security and traditional
medicine.201 Domestic legislative measures with respect to
198. For 2002, it is indicated that genetically engineered seed accounted for
seventy-five percent of the market: Bt cotton (thirty-five percent), RR cotton
(ten percent), and stacked varieties (thirty percent). See PSCHORN-STRAUSS &
JARDINE, supra note 179, at 3.
199. See id.
200. See The Significance of Genetic Resources in Africa, in AFRICAN
PERSPECTIVES ON GENETIC RESOURCES, supra note 18, at 9, 23.
201. Mushita & Thompson, supra note 13, at 80.
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indigenous knowledge and control and access to plant genetic
resources must respect this fact. In short, the provisions of the
CBD and the ITPGR should shield Africa against undue
pressure for domestic legislation to comply with the letter of
the law contained in the TRIPS Agreement.

